These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33460636)

  • 1. Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study.
    Averina M; Brox J; Huber S; Furberg AS
    Environ Res; 2021 Apr; 195():110740. PubMed ID: 33460636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study.
    Averina M; Huber S; Almås B; Brox J; Jacobsen BK; Furberg AS; Grimnes G
    Environ Res; 2024 Feb; 242():117703. PubMed ID: 37984785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl substances in adolescents in northern Norway: Lifestyle and dietary predictors. The Tromsø study, Fit Futures 1.
    Averina M; Brox J; Huber S; Furberg AS
    Environ Int; 2018 May; 114():123-130. PubMed ID: 29500988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum perfluoroalkyl substances (PFAS) and risk of asthma and various allergies in adolescents. The Tromsø study Fit Futures in Northern Norway.
    Averina M; Brox J; Huber S; Furberg AS; Sørensen M
    Environ Res; 2019 Feb; 169():114-121. PubMed ID: 30447498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.
    Kvalem HE; Nygaard UC; Lødrup Carlsen KC; Carlsen KH; Haug LS; Granum B
    Environ Int; 2020 Jan; 134():105259. PubMed ID: 31733527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PFAS Concentrations and Cardiometabolic Traits in Highly Exposed Children and Adolescents.
    Canova C; Di Nisio A; Barbieri G; Russo F; Fletcher T; Batzella E; Dalla Zuanna T; Pitter G
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults.
    Pitter G; Zare Jeddi M; Barbieri G; Gion M; Fabricio ASC; Daprà F; Russo F; Fletcher T; Canova C
    Environ Health; 2020 Sep; 19(1):102. PubMed ID: 32958007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project.
    Lopez-Espinosa MJ; Mondal D; Armstrong BG; Eskenazi B; Fletcher T
    Environ Health Perspect; 2016 Aug; 124(8):1269-75. PubMed ID: 26794451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort.
    Birukov A; Andersen LB; Andersen MS; Nielsen JH; Nielsen F; Kyhl HB; Jørgensen JS; Grandjean P; Dechend R; Jensen TK
    Environ Int; 2021 Jun; 151():106442. PubMed ID: 33610053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems.
    Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Bellinger DC; Webster TF; White RF; Sagiv SK
    Environ Res; 2021 Nov; 202():111621. PubMed ID: 34237332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of single and multiple perfluoroalkyl substances exposure with folate among adolescents in NHANES 2007-2010.
    Tian Y; Luan M; Zhang J; Yang H; Wang Y; Chen H
    Chemosphere; 2022 Nov; 307(Pt 3):135995. PubMed ID: 35981617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.
    Jain RB; Ducatman A
    Environ Pollut; 2018 Dec; 243(Pt A):1-8. PubMed ID: 30170203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins.
    Jain RB; Ducatman A
    Sci Total Environ; 2019 Feb; 653():74-81. PubMed ID: 30408670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
    Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
    Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.